DMD Main Curing DMD: Travelling together to find a meaningful destina... For many years, Duchenne muscular dystrophy (DMD) was something of a forgotten disease.
Disease Spotlight Increase collaboration to widen access to DMD drugs, trials ... When it comes to fighting a rare disease like Duchenne muscular dystrophy (DMD), it’s a matter of strength in numbers.
News Pfizer axes development of Duchenne muscular dystrophy antib... Pfizer has axed trials of its domagrozumab antibody for Duchenne muscular dystrophy (DMD), after it failed against efficacy targets.
News Sarepta dives deeper into gene therapy Sarepta Therapeutics has handed $30 million to Lacerta in exchange for a group of gene therapies, including a Pompe disease candidate.
Slider in home page He ain’t heavy – learning about a sibling’s DMD diagnosis It’s common for patients to want to know more about what’s causing them to be ill and their DMD diagnosis and it’s the same for their families – however long that road may be.
News OpenBind unveils its first AI model for drug discovery A research consortium that aims to make the UK a leader in AI-driven drug discovery, OpenBind, has hit its first major milestone.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
